Production and sales of finished dosage forms (FDF), active pharmaceutical ingredients (API), intermediates and chemicals.

Olainfarm manufactures more than 60 FDFs in various forms. Key areas of specialisation include neurology (cholinesterase inhibitors, anxiolytics, psychostimulants, nootropics), cardiology (antiarrhythmics, energy metabolism enhancers), infectology (original nitrofurantoine derivatives and antivirals) and allergology (fast-acting antihistamines).

Olainfarm produces 28 different APIs and more than 20 intermediates and chemicals. The company is experienced in adamantane derivatives, quinuclidine derivatives, nitrofuran derivatives and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

* The company participates in the In-depth Cooperation Programme and has been admitted to the Gold level.